Royal Fund Management’s Sanofi SNY Stock Holding History

Royal Fund Management’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-35	Closed	-$1K	–	665
2018 Q4	$1K	Buy	+35	New	+$1.54K	﹤0.01%	550

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Fund Management's SNY Position: Q1 2019 in Review

Royal Fund Management sold out of Sanofi (SNY) in Q1 2019, closing a stake of 35 shares — an estimated $1K sold.

Royal Fund Management first reported a position in SNY in Q4 2018 and held it in 1 quarter. The position peaked at $1K in Q4 2018. 489 funds tracked by Wall St. Rank hold SNY as of Q1 2019.

Royal Fund Management reported no remaining Sanofi position as of Q1 2019 after selling out during the quarter.
Royal Fund Management sold 35 Sanofi shares in Q1 2019, an estimated $1K.
Royal Fund Management first reported a position in Sanofi in Q4 2018 and held it in 1 quarter.
Royal Fund Management's Sanofi position peaked at $1K in Q4 2018.
489 funds tracked by Wall St. Rank held Sanofi as of Q1 2019.

Based on Royal Fund Management's 13F filing for Q1 2019, filed 11 May 2020.